Deep Brain Stimulation Systems Market, By Product Type (Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator), By Application (Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Deep Brain Stimulation Systems Market was valued at US$ 1.6 Billion in 2024 and is projected to grow at a CAGR of 14.6% to reach US$ 5.5 Billion by 2034.

[PDF] A surgical method called deep brain stimulation involves implanting a device that provides electrical signals to the areas of the brain responsible for coordinating movement. A deep brain stimulation (DBS) system consists of a lead, an extension, and a neuro-stimulator that are all implanted inside the body of the patient. The lead synchronizes electrical pulses by connecting the pacemaker device to the brain. DBS devices help to lessen the symptoms of stiffness and tremor caused by a variety of neurological diseases, such as Parkinson's disease, dystonia, or essential tremor. After deep brain stimulation surgery, patients can lower their medication dosage, perhaps eliminating any side effects.

The rising occurrence of neurological illnesses have become key factors in the growth of the Deep Brain Stimulation Systems Market. The rising prevalence of Parkinson's disease across globe continents has given rise to demand for target market. The demand for DBS devices will also increase due to the increased prevalence of essential tremors and dystonia has also become the major contribution in Deep Brain Stimulation Systems Market growth.

Rising prevalence of neurological disorders globally to accelerate the market demand

Surging number of neurological disorders worldwide, including Parkinson’s disease, epilepsy, Alzheimer’s, depression, dementia, multiple sclerosis, etc., is expected to foster the demand for deep brain stimulation devices. The adoption of new technological developments and scientific breakthroughs in healthcare settings are driving the growth of Deep Brain Stimulation Market.

For instance, in 2020, according to U.S Centers for Disease Control and Prevention (CDC), the number of Americans with Alzheimer's disease was estimated to be around 5.8 million, and by 2060, that number is expected to rise to 14 million. Deep brain stimulation techniques are expected to see strong demand as a result of this trend.

Furthermore, in 2022, according to the World Health Organization (WHO), 50 million individuals across the globe have been affected by epilepsy. Approximately 5 million people are diagnosed with epilepsy each year globally. Epilepsy is projected to affect 139 out of every 100,000 people in low to middle income countries each year, compared to 49 out of every 100,000 in high income nations.

Increasing incidence of Parkinson’s disease to foster the target market

Parkinson's disease (PD) is the second most prevalent neurodegenerative ailment after Alzheimer's disease, it is marked by worsening movement symptoms over time. In recent years, PD has undergone the fastest growth in prevalence and disability among neurological disorders, and it has become one of the leading causes of disability worldwide, which has driven the Deep Brain Stimulation Systems Market growth.

For instance, in 2019, according to U.S Centers for Disease Control and Prevention (CDC), from 1999 to 2017, age-adjusted death rates for Parkinson disease among adults of age group less than 65 years has increased from 41.7 to 65.3 per 100,000 population. Among men, the age-adjusted death rate increased from 65.2 per 100,000 in 1999 to 97.9 in 2017. Among women, the rate increased from 28.4 per 100,000 in 1999 to 43.0 in 2017. During 1999–2017, the death rates for Parkinson disease for men were higher than those for women.

For instance, in January 2022, ABL Bio Inc., a clinical-stage biotech developing bispecific antibody technology for immuno-oncology and neurodegenerative diseases announced a collaboration and a worldwide license agreement with SANOFI to develop and commercialize “ABL301”. It is a pre-clinical stage bispecific antibody targeting alpha-synuclein and insulin-like growth factor 1 receptor (IGF1R) to treat Parkinson's disease and other potential indications with enhanced blood-brain barrier (BBB) penetration.

Restrains:

Although deep brain stimulation is generally considered to be low risk, any type of surgery has the risk of complications. Side effects, such as allergic reaction and tingling or prickling of the skin, are a source of concern and are predicted to hinder the Deep Brain Stimulation Systems Market expansion. Deep brain stimulation systems are expected to face competition from various treatment options such as pharmacological therapy and surgery throughout the forecast period as complications of surgery includes misplacement of leads, bleeding in the brain, stroke, infection, breathing problems, etc.

Deep Brain Stimulation Systems Market is segmented based on Product Type, Application, End-Users and Region.

Product Type Insight

On the basis of Product Type, Deep Brain Stimulation Systems Market is segmented into single-channel deep brain stimulator and dual-channel deep brain stimulator. Dual-channel deep brain stimulator segment is expected to dominate the target market growth due to its higher adoption in surgical procedures. Dual channels are one of the safest and most efficient tools used in surgical procedures. The rising prevalence of debilitating neurological conditions, the rise in PD surgeries, and hospitals employing dual-channel DBS devices are all the factors contributing to the segment's expansion.

Application Insights

On the basis of Application, Deep Brain Stimulation Systems Market is segmented into Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, and Other Applications. Parkinson's Disease segment are expected to dominate the target market growth, owing to the factors such as aging populations, increasing longevity, by-products of industrialization, increasing number of U.S. Food and Drug Administration (FDA) approvals for deep brain stimulation therapies and the high prevalence of PD worldwide.

 

End-Users Insights

On the basis of End-Users, Deep Brain Stimulation Systems Market is segmented into Hospitals Ambulatory Surgical Centers, Neurological Clinics, and Other End Users. The Hospitals is expected to dominate the target market growth due to the rise in Parkinson's disease, essential tremor, and the rise in DBS procedures carried out in medical facilities. In addition, the availability of advanced DBS devices and suitable reimbursement guidelines would further boost the segment growth.

Regional Insights:

On the basis of region, the Deep Brain Stimulation Systems Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to factors such as government funding and the increase in awareness-building initiatives for Parkinson's disease (PD). The increase in Food and Drug Administration (FDA) approvals for deep brain stimulators for the treatment of PD, the presence of major competitors, availability of sophisticated healthcare infrastructure, are the few factors that is anticipated to increase demand for deep brain stimulation systems in the region.

 

Report Scope:

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Product Type - Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator By Application - Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, and Other Applications By End-Users - Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Other End Users
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Deep Brain Stimulation Systems Market report based on Product Type, Application, End-Users and Region:

Deep Brain Stimulation Systems Market, By Product Type:

• Single-channel Deep Brain Stimulator
• Dual-channel Deep Brain Stimulator

Deep Brain Stimulation Systems Market, By Application:

• Parkinson's Disease
• Essential Tremor
• Obsessive Compulsive Disorder
• Epilepsy
• Dystonia
• Other Applications

Deep Brain Stimulation Systems Market, By End-Users:

• Hospitals, Ambulatory Surgical Centers
• Neurological Clinics
• Other End Users

Deep Brain Stimulation Systems Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the Deep Brain Stimulation Systems Market includes, Abbott Laboratories (St. Jude Medical), Beijing PINS Medical Co. Ltd., Boston Scientific Corporation, Fisher Wallace, Functional Neuromodulation Ltd., Medtronic PLC, NeuroPace Inc., and Renishaw PLC.

• Abbott Laboratories (St. Jude Medical) *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Beijing PINS Medical Co. Ltd.
• Boston Scientific Corporation
• Fisher Wallace
• Functional Neuromodulation Ltd.
• Medtronic PLC
• NeuroPace Inc.
• Renishaw PLC.

“*” marked represents similar segmentation in other categories in the respective section.

Recent Development:

• In June 2021, The U.S. Food and Drug Administration (FDA) approved the first U.S. implants of the “SenSight™” Directional Lead System which was launched by Medtronic plc, the global leader in medical technology. SenSight™ is used for Deep Brain Stimulation (DBS) therapy and it is SenSight is the first-of-its-kind DBS directional lead that combines the power of sensing with the advantages of directionality, enabling medical professionals to administer precise patient-specific DBS therapy for the treatment of some symptoms related to movement disorders like Parkinson's disease, dystonia and essential tremor, as well as medically refractory epilepsy.
• In January 2020, The U.S. Food and Drug Administration (FDA) approved “Infinity™” Deep Brain Stimulation (DBS) system, launched by “Abbott”, a publicly listed company that creates breakthrough products in the area of diagnostics, medical devices, nutrition and branded generic pharmaceuticals. Infinity™ Deep Brain Stimulation (DBS) system includes the targeting of an area of the brain called the internal globus pallidus (GPi). The Infinity DBS is the only directional DBS system which is currently authorized for treating movement disorders, Parkinson's disease and essential Tremor.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Deep Brain Stimulation Systems Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Product Type
     • Market Snippet, By Application
     • Market Snippet, By End-user
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Global Deep Brain Stimulation Systems Market, By Product Type, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Single-channel Deep Brain Stimulator
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Dual-channel Deep Brain Stimulator
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
6. Global Deep Brain Stimulation Systems Market, By Application, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Parkinson's Disease
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Essential Tremor
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Obsessive Compulsive Disorder
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Epilepsy
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Dystonia
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Other Applications
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
7. Global Deep Brain Stimulation Systems Market, By End-user, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Hospitals
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Ambulatory Surgical Centres
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Neurological Clinics
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Other End Users
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
8. Global Deep Brain Stimulation Systems Market, By Region, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • Germany
       • UK
       • France
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • China
       • India
       • Japan
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
     • Market Size  and Forecast (US$ Mn), By Country, 2020 – 2030
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
9. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
10. Company Profiles
    • Abbott Laboratories (St. Jude Medical)
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Business Strategies
    • Beijing PINS Medical Co. Ltd.
    • Boston Scientific Corporation
    • Fisher Wallace
    • Functional Neuromodulation Ltd.
    • Medtronic PLC
    • NeuroPace Inc.
    • Renishaw PLC
11. The Last Word
    • Future Impact
    • About Us
    • Contact